PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled powder shows promise for Lung-Related high blood pressure
Disease control OngoingThis study tests the safety of an inhaled dry powder drug called LIQ861 (treprostinil) in 80 adults with pulmonary hypertension (high blood pressure in the lungs) linked to lung disease. Participants receive the drug through an inhaler, and researchers monitor for side effects. T…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated May 17, 2026 00:26 UTC
-
Could a cancer drug ease heart strain in rare genetic disease?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether the drug bevacizumab can help people with hereditary hemorrhagic telangiectasia (HHT) who have severe liver issues causing high heart output and possible heart failure. Researchers will track heart function before and after treatment in about 111 parti…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 17, 2026 00:26 UTC
-
Timing of cord clamping may save tiny lungs in rare birth defect
Disease control OngoingThis study looks at 140 babies born with a hole in their diaphragm (congenital diaphragmatic hernia). Doctors want to see if waiting to clamp the umbilical cord until after the baby's lungs have filled with air can lower the risk of dangerous high blood pressure in the lungs. The…
Matched conditions: PULMONARY HYPERTENSION
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug aims to boost walking distance in lung patients
Disease control OngoingThis study tests an experimental drug called MK-5475 (frespaciguat) in 129 adults who have high blood pressure in the lungs caused by chronic lung disease (COPD). The main goal is to see if the drug helps people walk farther in 6 minutes after 24 weeks compared to a placebo. The …
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:15 UTC
-
New hope for PAH patients: Long-Term drug safety trial underway
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who have already been in earlier ralinepag studies will take the drug and be monitored f…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New inhaled therapy shows promise for Hard-to-Treat lung condition
Disease control OngoingThis study tests an inhaled medicine called mosliciguat in 135 people who have high blood pressure in their lungs due to scarring lung disease. The goal is to see if it improves blood flow and walking ability over 16 weeks. Participants are randomly assigned to receive the drug o…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New screening method aims to catch hidden Heart-Lung condition early
Diagnosis OngoingThis study tests whether special screening methods can find pulmonary hypertension (high blood pressure in the lungs) earlier in people with interstitial lung disease. About 300 adults with various types of ILD will be screened using heart catheterization to confirm the condition…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: United Therapeutics • Aim: Diagnosis
Last updated May 07, 2026 18:41 UTC
-
New heart scan aims to catch deadly lung pressure sooner
Diagnosis OngoingThis study is testing a new computer method called the IMPULSE algorithm to see if it can spot pulmonary hypertension (high blood pressure in the lungs) better than current guidelines. It involves 200 patients who are already getting a standard heart ultrasound scan for unexplain…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Diagnosis
Last updated Apr 06, 2026 14:05 UTC
-
Exercise may boost heart health in lung hypertension patients
Symptom relief TerminatedThis study looks at whether a supervised exercise program can improve heart function and quality of life for people with heart failure and pulmonary hypertension (high blood pressure in the lungs). Researchers will measure oxygen use during exercise and blood pressure in the lung…
Matched conditions: PULMONARY HYPERTENSION
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Simple breathing workouts may ease rare lung condition
Symptom relief ENROLLING_BY_INVITATIONThis small study tests whether six weeks of special breathing exercises (called inspiratory muscle strength training) can improve heart and lung function in people with pulmonary hypertension, a condition where blood pressure in the lungs is too high. Four participants will do th…
Matched conditions: PULMONARY HYPERTENSION
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 07, 2026 18:43 UTC
-
Heart study pulled before it started: no volunteers enrolled
Knowledge-focused TerminatedThis study was designed to look for early signs of lung blood pressure problems in adults after mitral valve surgery. Researchers planned to use blood tests and heart imaging to find hidden risks. However, the study was withdrawn before enrolling any participants.
Matched conditions: PULMONARY HYPERTENSION
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 17, 2026 00:24 UTC
-
Short step test may replace long walk for lung patients
Knowledge-focused OngoingThis study checks if a 2-minute step test works as well as the standard 6-minute walk test for people with pulmonary hypertension. About 35 adults will do both tests while wearing a portable device that measures oxygen use and heart rate. The goal is to see if the shorter, simple…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Blood markers may guide smarter PH therapy choices
Knowledge-focused OngoingThis study looks at whether measuring certain substances in the blood of people with pulmonary hypertension (PH) can help doctors pick the best treatment. About 100 adults getting a standard heart test for PH will also have these extra measurements. The goal is to see if this lea…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Blood test may predict lung transplant or death risk in PH patients
Knowledge-focused OngoingThis study is investigating whether two substances in the blood, Activin-A and FSTL3, can help predict how well people with pulmonary hypertension will do over time. Researchers will follow 550 adults with different types of this condition to see if these markers are linked to th…
Matched conditions: PULMONARY HYPERTENSION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
New study links biomarkers to kidney decline in lung patients
Knowledge-focused OngoingThis study examines the connection between certain biomarkers (substances in urine and blood) and kidney function decline in 350 adults with pulmonary hypertension, a type of high blood pressure affecting the lungs. Participants undergo a heart procedure and are followed to see i…
Matched conditions: PULMONARY HYPERTENSION
Sponsor: University of Giessen • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC
-
Fitness trackers vs. walking tests: which better predicts lung disease outcomes?
Knowledge-focused OngoingThis study looks at whether wearing an activity tracker (like a Fitbit) can better predict how people with pulmonary hypertension will do over 12 weeks compared to the standard 6-minute walk test. About 230 participants will wear the tracker and report how they feel. The goal is …
Matched conditions: PULMONARY HYPERTENSION
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC